These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37202684)

  • 1. [Not Available].
    Thomas A
    MMW Fortschr Med; 2023 May; 165(10):28. PubMed ID: 37202684
    [No Abstract]   [Full Text] [Related]  

  • 2. Sensor Augmented Pump Therapy is Safe and Effective in Very Low Birth Weight Newborns Affected by Neonatal Diabetes Mellitus, With Poor Subcutaneous Tissue: Replacement of the Insulin Pump Infusion Set on the Arm, a Video Case Report.
    Zanfardino A; Carpentieri M; Piscopo A; Curto S; Miraglia Del Giudice E; Inverardi A; Diplomatico M; Moschella S; Spagnuolo F; Caredda E; Montaldo P; Iafusco D
    J Diabetes Sci Technol; 2022 Jan; 16(1):254-255. PubMed ID: 34474595
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of portal/peripheral route and of algorithms for insulin delivery in the closed-loop control of glucose in diabetes--a modeling study.
    Cobelli C; Ruggeri A
    IEEE Trans Biomed Eng; 1983 Feb; 30(2):93-103. PubMed ID: 6339366
    [No Abstract]   [Full Text] [Related]  

  • 4. Basal-rate intravenous insulin infusion compared to conventional insulin treatment in patients with type II diabetes. A prospective crossover trial.
    Blackshear PJ; Roussell AM; Cohen AM; Nathan DM
    Diabetes Care; 1989; 12(7):455-63. PubMed ID: 2667926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial.
    Battelino T; Conget I; Olsen B; Schütz-Fuhrmann I; Hommel E; Hoogma R; Schierloh U; Sulli N; Bolinder J;
    Diabetologia; 2012 Dec; 55(12):3155-62. PubMed ID: 22965294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system.
    Peyrot M; Rubin RR
    Diabetes Technol Ther; 2009 Jan; 11(1):57-62. PubMed ID: 19132857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The single-port concept: combining optical glucose measurement with insulin infusion.
    Hajnsek M; Nacht B; Sax S; List EJ; Klimant I; Sinner F
    Acta Diabetol; 2014 Oct; 51(5):883-6. PubMed ID: 24687695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion.
    Weintrob N; Schechter A; Benzaquen H; Shalitin S; Lilos P; Galatzer A; Phillip M
    Arch Pediatr Adolesc Med; 2004 Jul; 158(7):677-84. PubMed ID: 15237068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal insulin substitution with glargine or continuous subcutaneous insulin infusion in adult type 1 diabetes patients-a randomized controlled trial.
    Bragd J; von Döbeln A; Lins PE; Adamson U; Bergström J; Oskarsson P
    Diabetes Technol Ther; 2010 Sep; 12(9):689-93. PubMed ID: 20687863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes.
    Cobry E; McFann K; Messer L; Gage V; VanderWel B; Horton L; Chase HP
    Diabetes Technol Ther; 2010 Mar; 12(3):173-7. PubMed ID: 20151766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes.
    Nimri R; Battelino T; Laffel LM; Slover RH; Schatz D; Weinzimer SA; Dovc K; Danne T; Phillip M;
    Nat Med; 2020 Sep; 26(9):1380-1384. PubMed ID: 32908282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus-basal insulin regimens: An analysis from the OpT2mise randomized trial.
    Metzger M; Castañeda J; Reznik Y; Giorgino F; Conget I; Aronson R; de Portu S; Runzis S; Lee SW; Cohen O
    Diabetes Obes Metab; 2017 Oct; 19(10):1490-1494. PubMed ID: 28374511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose Sensor.
    Christiansen MP; Garg SK; Brazg R; Bode BW; Bailey TS; Slover RH; Sullivan A; Huang S; Shin J; Lee SW; Kaufman FR
    Diabetes Technol Ther; 2017 Aug; 19(8):446-456. PubMed ID: 28700272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adsorption of insulin directly added to infusion bottles].
    Canivet B; Berre A; Macchi P; Grimaud D; Maestracci P; Freychet P
    Sem Hop; 1983 May; 59(18):1405-8. PubMed ID: 6306826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal insulin infusion resulting from a mathematical model of blood glucose dynamics.
    Fisher ME; Teo KL
    IEEE Trans Biomed Eng; 1989 Apr; 36(4):479-86. PubMed ID: 2714828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous insulin infusion system to determine insulin regimen in diabetics.
    Ito M; Sato T; Saito T; Kokubun M; Inoue M; Saito K; Yoshinaga K
    Tohoku J Exp Med; 1988 Jan; 154(1):29-36. PubMed ID: 3284000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of a nonlinear model to describe the blood glucose response for the determination of prandial insulin infusion.
    Hirayama H; Kasuya Y; Yagishita A; Katakura T
    J Pharmacobiodyn; 1985 Oct; 8(10):819-29. PubMed ID: 3912488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental and application of insulin infusion profiles for therapy of type-I diabetics with portable insulin infusion systems.
    Schulz G; Strack T; Beyer J; Krause U; Cordes U; Weber T; Nagel J; Beutelspacher F
    Life Support Syst; 1984; 2(3):189-200. PubMed ID: 6503348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of insulin-dependent diabetes by continuous subcutaneous infusion of insulin (author's transl)].
    Buysschaert M; Lejeune M; Lambert AE
    Ann Endocrinol (Paris); 1981; 42(3):293-4. PubMed ID: 7316465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.
    Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW
    Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.